Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shivaji R Manthena

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurology and Therapy|June 5, 2026
Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims AnalysisNing Cheng, Annaliza Dominguez, Shivaji R Manthena, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevirDavid R Walker, Timothy R Juday, Shivaji R Manthena, et al.
Advances in Therapy|June 28, 2018
Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016Viktor V Chirikov, Steven E Marx, Shivaji R Manthena, et al.
Advances in Therapy|November 6, 2015
Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)David R Walker, Marcos C Pedrosa, Shivaji R Manthena, et al.
Obstetrics and Gynecology|May 29, 2019
Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With BenzodiazepinesGeorgine Lamvu, Ahmed M Soliman, Shivaji R Manthena, et al.
Advances in Therapy|October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurology and Therapy|June 5, 2026
Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims AnalysisNing Cheng, Annaliza Dominguez, Shivaji R Manthena, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevirDavid R Walker, Timothy R Juday, Shivaji R Manthena, et al.
Advances in Therapy|June 28, 2018
Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016Viktor V Chirikov, Steven E Marx, Shivaji R Manthena, et al.
Advances in Therapy|November 6, 2015
Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)David R Walker, Marcos C Pedrosa, Shivaji R Manthena, et al.
Obstetrics and Gynecology|May 29, 2019
Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With BenzodiazepinesGeorgine Lamvu, Ahmed M Soliman, Shivaji R Manthena, et al.
Advances in Therapy|October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Pageof 1